Zurueck zur Suche

Reporte zur Charge U7296AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

13Reporte angezeigt
0Todesfaelle
2Hospitalisiert
2Lebensbedrohlich
0Bleibende Schaeden
AZ 2 MN 2 WA 2 MI 1 AL 1 CA 1 PA 1 FL 1 MO 1 MA 1

VAERS 2626686

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

schwer
Staat
MI
Alter
0,5
Geschlecht
M
Eingang
04.05.2023
Impfdatum
03.05.2023
Beginn
04.05.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood glucose increased Blood lactic acid Blood sodium normal Haemoglobin normal Pyrexia Seizure Status epilepticus White blood cell count White blood cell count normal

Symptomtext

Generalized seizure beginning around 10:15 on 5/4/23, which continued in the ED. Fever was present to 38.3 C. Status epilepticus requiring multiple medications to stop seizure. Admitted to hospital for sepsis evaluation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Sodium 138, glucose 123, wbc 16.9, hemoglobin 12.5, PMNs 9.4, lactic acid 3.7. CXR and blood cultures ordered.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2727921

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

mild
Staat
AL
Alter
-
Geschlecht
M
Eingang
28.12.2023
Impfdatum
24.07.2023
Beginn
16.11.2023
Tage bis Beginn
115,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Rash

Symptomtext

mom states she is doing well, but has a rash; The HCP reported that a 6month old patient inadvertently received a dose of VARIVAX; This non-serious spontaneous safety report, with Agency Case ID number: 02509272, was received by a partner on 27-NOV-2023 and forwarded to Agency on 30-NOV-2023, from a HCP. This case was considered as non-valid (No clarification about administration of Vaxelis). Due to the nature of the event, the causality between the event " The HCP reported that a 6month old patient inadvertently received a dose of VARIVAX" and Vaxelis was assessed as not applicable. Further information is expected. Follow-up information was received by Agency on 05-DEC-2023, from a HCP. The case is maintained as non-serious and no longer non-valid (as vaxelis was administered) Due to the nature of the event, the causality between the event " The HCP reported that a 6month old patient inadvertently received a dose of VARIVAX" and Vaxelis was assessed as not applicable. Further information is expected. Follow-up information was received by Agency on 19-DEC-2023, from a HCP. The case is maintained as non-serious and Valid. The reporter did not provide an assessment of the causal relationship between Vaxelis and the event 'mom states she is doing well but has a rash' and the casual relationship between Vaxelis and event ' The HCP reported that a 6month old patient inadvertently received a dose of VARIVAX' was assessed as not applicable due to the nature of these reported event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis; Rash
Vorgeschichte
-
Andere Medikamente
ROTATEQ; VAXNEUVANCE
Allergien
-
Vorherige Impfungen
-

VAERS 2675119

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

mild
Staat
AZ
Alter
-
Geschlecht
U
Eingang
28.12.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site mass

Symptomtext

Noticed a lump at pt vaccine site; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2675119-1. The original narrative from the sender is the following: "Noticed a lump at pt vaccine site". The reporter assessed the causal relationship between Vaxelis and the events "Injection site mass" as related. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site mass
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2675119

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

mild
Staat
AZ
Alter
-
Geschlecht
U
Eingang
28.12.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site mass

Symptomtext

Noticed a lump at pt vaccine site; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS Primary ID 2675119-1. The original narrative from the sender is the following: "Noticed a lump at pt vaccine site". The reporter assessed the causal relationship between Vaxelis and the events "Injection site mass" as related. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site mass
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2721376

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

mild
Staat
CA
Alter
0,7
Geschlecht
M
Eingang
06.12.2023
Impfdatum
29.11.2023
Beginn
29.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cyanosis Lethargy Oedema peripheral Pyrexia

Symptomtext

PERIPHERAL EXTREMITY EDEMA, CENTRAL ACROCYANOSIS, FEVER, LETHARGY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
PARAMEDICS EVALUATION, IBUPROFEN
Aktuelle Erkrankungen
FEVER , VIRAL URI
Vorgeschichte
-
Andere Medikamente
IBUPROFEN
Allergien
NKA
Vorherige Impfungen
-

VAERS 2674478

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
MN
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
21.08.2023
Beginn
21.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product use issue Unevaluable event

Symptomtext

Attempt to reach arent with assistance of interpreter to check on patient.Left message to call the office; product use in unapproved population; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS primary ID 2674478-1. The original narrative from the sender is as follows. "Attempt to reach parent with assistance of interpreter to check on patient. Left a message to call the office." The case was classified as non-valid given that the reported event was "Unevaluable event". Due to the nature of the event, the causal relationship between Vaxelis and "Unevaluable event" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2674478

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
MN
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
21.08.2023
Beginn
21.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product use issue Unevaluable event

Symptomtext

Attempt to reach arent with assistance of interpreter to check on patient.Left message to call the office; product use in unapproved population; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-OCT-2023 with the following VAERS primary ID 2674478-1. The original narrative from the sender is as follows. "Attempt to reach parent with assistance of interpreter to check on patient. Left a message to call the office." The case was classified as non-valid given that the reported event was "Unevaluable event". Due to the nature of the event, the causal relationship between Vaxelis and "Unevaluable event" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689423

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
02.10.2023
Impfdatum
08.08.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Previously received Pentacel but what about Pediarix? We have a little one who received Pediarix at 2 & 4 months but when he came in for his 6 month well child check, he was given Vaxelis.No additional information available from this first contact; This spontaneous non -serious safety report, with reference number 2023SA244561 (Inquiry number), was received by the partner on 08-AUG-2023 and forwarded to agency on 10-AUG-2023, from a health professional. The causal relationship between Vaxelis and the reported event " Previously received Pentacel but what about Pediarix? We have a little one who received Pediarix at 2 & 4 months but when he came in for his 6 months well child check, he was given Vaxelis. No additional information available from this first contact" was assessed as not applicable due to the nature of the event. Further information is expected. Significant follow-up information was received by agency on 06-SEP-2023, from a HCP. The case is maintained as non-serious. The causal relationship between Vaxelis and the reported event " Previously received Pentacel but what about Pediarix? We have a little one who received Pediarix at 2 & 4 months but when he came in for his 6 months well child check, he was given Vaxelis. No additional information available from this first contact" was assessed as not applicable due to the nature of the event. No further information is expected. NI is not working, added State under vaccine facility information and Reporter State.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2647999

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
FL
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
06.04.2023
Beginn
06.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Dyskinesia

Symptomtext

Crying involuntary movement; Crying involuntary movement; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2647999-1. The original narrative from the sender is the following: Concomitant medications include acetaminophen. "Crying Involuntary movement". The reporter did not provide the causal relationship between Vaxelis and the events, "Crying Involuntary movement". Non-significant follow up information received from partner with reference number #2647999 on 25-JUL-2023 and forwarded to agency on 28-JUL-2023 from a health care professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events of "Crying involuntary movement". Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Crying
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
ACETAMINOPHEN
Allergien
-
Vorherige Impfungen
-

VAERS 2642961

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
MO
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
07.06.2023
Beginn
07.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient was mistakenly administered Pneumovax23 which is not recommended for children under 2 years; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2642961-1. The original narrative from the sender is the following: "The patient was mistakenly administered Pneumovax23 which is not recommended for children under 2 years. Attempts have been made to contact parents, but I have not been able to reach them, so it is unknown if there has been an adverse effect". The causal relationship between Vaxelis and the event "Patient was mistakenly administered Pneumovax23 which is not recommended for children under 2 years" was assessed as not applicable due to the nature of this event. Of note, these events do not concern Vaxelis, but rather Pneumovax23 vaccine. Vaxelis should have been considered as a concomitant. However, the case was databased to mirror what was reported in VAERS. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2651134

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
MA
Alter
-
Geschlecht
M
Eingang
21.07.2023
Impfdatum
25.04.2023
Beginn
08.05.2023
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Barium enema Blood culture C-reactive protein Culture urine Full blood count Intussusception Metabolic function test Occult blood Procalcitonin Ultrasound abdomen Urine analysis

Symptomtext

Intussusception diagnosed on 5/10 (15 days following the rota virus vaccine); Barium enema; Culture urine; Occult blood; Utrasound Abdomen; Urine analysis; Procalcitonin; Full blood count; Blood culture; C-reactive protein; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2023 with the following VAERS Primary ID 2651134-1. The original narrative from the sender is as follows: Intussusception was diagnosed on 10-May-2023 (15 days following the rotavirus vaccine). On 08-MAY-2023, CBC (complete blood count), CRP (C-reactive protein), CMP (complete metabolic panel), blood culture, procalcitonin, urinalysis, and urine culture was performed. On 10-MAY-2023, fecal occult blood, ultrasound abdomen, and reduction using barium enema procedure was performed. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event "Intussusception". Due to the nature of the event the causal relationship between Vaxelis and the events, "barium enema, blood culture, C-reactive protein, culture urine, full blood count, occult blood, procalcitonin, ultrasound abdomen, urine analysis" is not applicable. No further information is expected. COMPANY COMMENT: Intussusception was assessed as serious due to causing hospitalization and being life-threatening, whereas barium enema, blood culture, c-reactive protein, culture urine, full blood count, occult blood, procalcitonin, ultrasound abdomen, urine analysis, and urine culture were assessed as non-serious. Intussusception, CBC, CRP, CMP, blood culture, procalcitonin, urinalysis, and urine culture are unlisted for Vaxelis as per the Safety Information. Considering the current knowledge on Vaxelis and despite the co-suspect vaccines as confounding factor and lack of information in this case (no medical history), the causal relationship between Vaxelis and the reported event Intussusception cannot be excluded and is assessed as related. However, due to background incidence in the pediatric population, an independent event needs to be taken into consideration. Due to the nature of the events, the causal relationship between Vaxelis and barium enema, blood culture, C-reactive protein, culture urine, full blood count, occult blood, procalcitonin, ultrasound abdomen, urine analysis was assessed as not applicable.; Sender's Comments: Intussusception was assessed as serious due to causing hospitalization and being life-threatening, whereas barium enema, blood culture, c-reactive protein, culture urine, full blood count, occult blood, procalcitonin, ultrasound abdomen, urine analysis, and urine culture were assessed as non-serious. Intussusception, CBC, CRP, CMP, blood culture, procalcitonin, urinalysis, and urine culture are unlisted for Vaxelis as per the Safety Information. Considering the current knowledge on Vaxelis and despite the co-suspect vaccines as confounding factor and lack of information in this case (no medical history), the causal relationship between Vaxelis and the reported event Intussusception cannot be excluded and is assessed as related. However, due to background incidence in the pediatric population, an independent event needs to be taken into consideration. Due to the nature of the event, the causal relationship between Vaxelis and barium enema, blood culture, C-reactive protein, culture urine, full blood count, occult blood, procalcitonin, ultrasound abdomen, urine analysis was assessed as not applicable.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Barium enema
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2651761

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge u7296aa

gering
Staat
WA
Alter
0,8
Geschlecht
M
Eingang
30.06.2023
Impfdatum
07.06.2023
Beginn
07.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Gave 6 month vaccines accidentally at 9 months clinic visit. No negative outcome has been reported to clinic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2644669

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7296AA

gering
Staat
WA
Alter
0,3
Geschlecht
F
Eingang
13.06.2023
Impfdatum
18.05.2023
Beginn
18.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

DTAP-IPV-HIB-HEPB & HIB given at same time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-